Phospho-TSC2 (Ser939) Recombinant antibody
Phospho-TSC2 (Ser939) Uni-rAbTM Recombinant Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
Human
Applications
WB, ELISA
Conjugate
Unconjugated
CloneNo.
2B18
Cat no : 81654-1-RR
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | Calyculin A treated HEK-293 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:5000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
81654-1-RR targets Phospho-TSC2 (Ser939) in WB, ELISA applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | Peptide |
Full Name | tuberous sclerosis 2 |
Calculated Molecular Weight | 1807 aa, 201 kDa |
Observed Molecular Weight | 200 kDa |
GenBank Accession Number | BC150300 |
Gene Symbol | TSC2 |
Gene ID (NCBI) | 7249 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TSC2, also named Tuberin, plays an essential role in the cellular energy response pathway. TSC2 forms a physical and functional complex with TSC1 that can inhibit the nutrient-mediated or growth factor-stimulated phosphorylation of S6K1 and EIF4EBP1 by negatively regulating mTORC1 signaling. Tuberin is phosphorylated on Ser939 and Thr1462 in response to PI3K activation and the human TSC complex is a direct biochemical target of the PI3K/Akt pathway (PMID: 12150915).
Protocols
Product Specific Protocols | |
---|---|
WB protocol for Phospho-TSC2 (Ser939) antibody 81654-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |